Vorinol Injection
Vorinol Injection contains Voriconazole 200 mg, a broad-spectrum triazole antifungal agent used for the treatment of serious and life-threatening fungal infections. It is particularly effective against Aspergillus species, Candida species (including fluconazole-resistant strains), and other invasive fungal pathogens.
Voriconazole works by inhibiting fungal cell membrane synthesis through blockade of ergosterol production, leading to fungal cell death. Vorinol Injection is widely used in the management of invasive aspergillosis, candidemia, esophageal candidiasis, and other severe systemic fungal infections, especially in immunocompromised and critically ill patients.
This formulation is supplied as a lyophilized powder and is intended for intravenous infusion only, to be diluted prior to administration. It ensures accurate dosing, rapid systemic availability, and consistent therapeutic efficacy in hospital settings.
Manufactured under strict quality control standards, Vorinol Injection offers high purity, stability, and reliable antifungal activity, making it a trusted choice for healthcare professionals.
Key Features:
- Voriconazole Injection IP 200 mg
- Broad-spectrum triazole antifungal agent
- Effective against invasive and resistant fungal infections
- Lyophilized powder for IV infusion only
- Suitable for critical care and immunocompromised patients
Vorinol Injection supports effective antifungal therapy and improved clinical outcomes in severe fungal infections.
Disclaimer:
This information is for registered medical practitioner only. Anyone other than medical practitioner should consult medical practitioner before using this product.